Literature DB >> 29485228

Driving performance of stable outpatients with depression undergoing real-world treatment.

Akemi Miyata1, Kunihiro Iwamoto1, Naoko Kawano1,2, Branko Aleksic1, Masahiko Ando3, Kazutoshi Ebe4,5, Kiyoshi Fujita6, Motonori Yokoyama7, Tsuyoshi Akiyama8, Yoshio Igarashi9, Norio Ozaki1.   

Abstract

AIM: Although the effects of psychotropics on driving ability have received much attention, little research is available on driving performance of stable outpatients with depression undergoing real-world treatment. This observational study investigated driving performance, cognitive functions, and depressive symptomatology of partly remitted outpatients with depression under daily-practice psychopharmacologic treatment.
METHODS: Seventy stable outpatients with depression and 67 healthy volunteers were enrolled. Patients' prescriptions were not controlled in order to capture the real-world treatment environment. Participants underwent three driving tasks - road-tracking, car-following, and harsh-braking - using a driving simulator, and three cognitive tasks - Continuous Performance Test, Wisconsin Card Sorting Test, and Trail-Making Test. The Symptom Assessment Scale - Structured Interview Guide for the Hamilton Depression Rating Scale, Beck Depression Inventory-II, Social Adaptation Self-Evaluation Scale, and Stanford Sleepiness Scale were also completed.
RESULTS: Although many patients received various pharmacologic treatments, there were no significant differences in the three driving tasks between outpatients with depression and healthy controls. Difficulty of maintaining set in the Wisconsin Card Sorting Test was significantly increased in patients with depression. Results on the Social Adaptation Self-Evaluation Scale were significantly associated with road-tracking and car-following performance, in contrast to results on the Hamilton Depression Rating Scale and the Beck Depression Inventory-II.
CONCLUSION: We conclude that partly remitted depressive patients under steady-state pharmacologic treatment do not differ from healthy controls with respect to driving performance, which seems to be more affected by psychosocial functioning than by pharmacologic agents. This, however, should be investigated systematically in an off/on study.
© 2018 The Authors. Psychiatry and Clinical Neurosciences © 2018 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  antidepressants; cognitive function; driving performance; driving simulator; major depressive disorder

Mesh:

Substances:

Year:  2018        PMID: 29485228     DOI: 10.1111/pcn.12648

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  3 in total

Review 1.  A Systematic Review of Executive Function and Information Processing Speed in Major Depression Disorder.

Authors:  Laura Nuño; Juana Gómez-Benito; Viviana R Carmona; Oscar Pino
Journal:  Brain Sci       Date:  2021-01-22

2.  Neuropsychological exponents for the driving ability in remitted bipolar patients.

Authors:  Piotr Joachimiak; Krystyna Jaracz; Jan Jaracz
Journal:  Int J Bipolar Disord       Date:  2022-01-23

3.  Driving Performance Under Treatment of Most Frequently Prescribed Drugs for Mental Disorders: A Systematic Review of Patient Studies.

Authors:  Alexander Brunnauer; Florian Herpich; Peter Zwanzger; Gerd Laux
Journal:  Int J Neuropsychopharmacol       Date:  2021-09-21       Impact factor: 5.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.